PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS AFTER DIFFERENT DOSES OF THE RACEMATE

被引:23
作者
GEISSLINGER, G
MENZEL, S
WISSEL, K
BRUNE, K
机构
[1] Department of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nurnberg
关键词
KETOPROFEN; PHARMACOKINETICS; ENANTIOMERS; STEREOSELECTIVITY;
D O I
10.1111/j.1365-2125.1995.tb04537.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics of the enantiomers of ketoprofen after oral administration of 12.5 mg, 25 mg and 50 mg and i.v. administration of 50 mg racemic ketoprofen to 24 healthy subjects were investigated. The AUC values of R- (r(2) = 0.929) and S-ketoprofen (r(2) = 0.930) were proportional to dose. The absolute bioavailability of the 50 mg oral dose was 84.5 (s.d. 20.6) % and 81.4 (18.0) % for R-ketoprofen and S-ketoprofen, respectively. With the exception of AUC values no dose dependent differences in pharmacokinetic parameters were observed. However, the R-enantiomer had higher AUG, lower clearance data and higher C-max values than the S-form after oral administration. The results suggest that stereochemical and pharmacokinetic considerations cannot explain the lack of dose response observed with ketoprofen doses below 50 mg.
引用
收藏
页码:73 / 75
页数:3
相关论文
共 10 条
[1]   PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS IN HEALTHY-SUBJECTS FOLLOWING SINGLE AND MULTIPLE DOSES [J].
FOSTER, RT ;
JAMALI, F ;
RUSSELL, AS ;
ALBALLA, SR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (01) :70-73
[2]   PHARMACOKINETICS OF KETOPROFEN ENANTIOMERS IN YOUNG AND ELDERLY ARTHRITIC PATIENTS FOLLOWING SINGLE AND MULTIPLE DOSES [J].
FOSTER, RT ;
JAMALI, F ;
RUSSELL, AS ;
ALBALLA, SR .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (03) :191-195
[3]   THE INFLUENCE OF RENAL-FUNCTION ON THE ENANTIOSELECTIVE PHARMACOKINETICS AND PHARMACODYNAMICS OF KETOPROFEN IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
HAYBALL, PJ ;
NATION, RL ;
BOCHNER, F ;
SANSOM, LN ;
AHERN, MJ ;
SMITH, MD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (03) :185-193
[4]  
Heinzel G, 1993, TOPFIT 2 0 PHARMACOK
[5]   CLINICAL PHARMACOKINETICS OF KETOPROFEN AND ITS ENANTIOMERS [J].
JAMALI, F ;
BROCKS, DR .
CLINICAL PHARMACOKINETICS, 1990, 19 (03) :197-217
[6]   A DOUBLE-BLIND PARALLEL COMPARISON OF KETOPROFEN, CODEINE, AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE POSTPARTUM PAIN [J].
KANTOR, T ;
CAVALIERE, MB ;
HOPPER, M ;
ROEPKE, S .
JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (5-6) :228-234
[7]   DOUBLE-BLIND PARALLEL COMPARISON OF SINGLE ORAL DOSES OF KETOPROFEN, CODEINE, AND PLACEBO IN PATIENTS WITH MODERATE TO SEVERE DENTAL PAIN [J].
MEHLISCH, D ;
FRAKES, L ;
CAVALIERE, MB ;
GELMAN, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (11-1) :486-492
[8]   STEREOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF KETOPROFEN, IBUPROFEN AND FENOPROFEN IN PLASMA USING A CHIRAL ALPHA-1-ACID GLYCOPROTEIN COLUMN [J].
MENZELSOGLOWEK, S ;
GEISSLINGER, G ;
BRUNE, K .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 532 (02) :295-303
[9]   THE DISPOSITION OF KETOPROFEN ENANTIOMERS IN MAN [J].
SALLUSTIO, BC ;
PURDIE, YJ ;
WHITEHEAD, AG ;
AHERN, MJ ;
MEFFIN, PJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (06) :765-770
[10]   A DOUBLE-BLIND, PARALLEL COMPARISON OF KETOPROFEN, ASPIRIN, AND PLACEBO IN PATIENTS WITH POSTPARTUM PAIN [J].
SUNSHINE, A ;
ZIGHELBOIM, I ;
LASKA, E ;
SIEGEL, C ;
OLSON, NZ ;
DECASTRO, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (08) :706-711